MedPath

Study on Carbapenem Resistance in India

Not Applicable
Conditions
Health Condition 1: null- Hospital admitted
Registration Number
CTRI/2017/01/007698
Lead Sponsor
MSD Pharmaceuticals Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
1500
Inclusion Criteria

•Patients admitted in the ICU & Wards from Jan â?? Dec 2015 & whose culture samples were tested for Group 1 &/or 2 carbapenems.

•Samples from clinical infections/sterile sites (Pleura, pericardium, peritoneum, CSF, Blood & non catheterized urine).

•All community (resistance +ve less than 48 hrs from admission) & hospital acquired (resistance +ve more than 48 hrs from admission) carbapenem & colistin resistant cases.

Exclusion Criteria

•Samples from potential colonization sites like skin swabs, pus, sputum & catheterized urine (to eliminate colonizers

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath